参考文献/References:
[1]Nienaber CA,Clough RE,Sakalihasan N,et al. Aortic dissection[J]. Nat Rev Dis Primers,2016,2:16071.
[2]Mussa FF,Horton JD,Moridzadeh R,et al. Acute aortic dissection and intramural hematoma:a systematic review[J]. JAMA,2016,316(7):754-763.
[3]Smedberg C,Steuer J,Leander K,et al. Sex differences and temporal trends in aortic dissection:a population-based study of incidence,treatment strategies,and outcome in Swedish patients during 15 years[J]. Eur Heart J,2020,41(26):2430-2438.
[4]Thunstr?m S,Krantz E,Thunstr?m E,et al. Incidence of aortic dissection in Turner syndrome[J]. Circulation,2019,139(24):2802-2804.
[5]Golledge J,Eagle KA. Acute aortic dissection[J]. Lancet,2008,372(9632):55-66.
[6]Beckmann E,Martens A,Kaufeld T,et al. Frozen elephant trunk in acute aortic type a dissection:risk analysis of concomitant root replacement[J]. Eur J Cardiothorac Surg,2022:ezac051.
[7]Huang B,Tian L,Chen Z,et al. Angiopoietin 2 as a novel potential biomarker for acute aortic dissection[J]. Front Cardiovasc Med,2021,8:743519.
[8]Segreto A,Chiusaroli A,de Salvatore S,et al. Biomarkers for the diagnosis of aortic dissection[J]. J Card Surg,2014,29(4):507-511.
[9]Wen D,Du X,Dong JZ,et al. Value of D-dimer and C reactive protein in predicting inhospital death in acute aortic dissection[J]. Heart,2013,99(16):1192-1197.
[10]Mori K,Tamune H,Tanaka H,et al. Admission values of D-dimer and C-reactive protein(CRP) predict the long-term outcomes in acute aortic dissection[J]. Intern Med,2016,55(14):1837-1843.
[11]Bossone E,LaBounty TM,Eagle KA. Acute aortic syndromes:diagnosis and management,an update[J]. Eur Heart J,2018,39(9):739d-744d.
[12]Yang G,Peng W,Zhou Y,et al. Characteristics and prognosis of acute type A aortic dissection with negative D-dimer result [J]. Am J Emerg Med,2020,38(9):1820-1834.
[13]曹德满. 血清α-羟丁酸脱氢酶对急性心肌梗塞的诊断意义[J]. 中华临床医学研究杂志,2006,12(8):1117-1118.
[14]Ohlmann P,Jaquemin L,Morel O,et al. Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction[J]. Am Heart J,2006,152(6):1161-1167.
[15]Dissmann R,Linderer T,Schr?der R. Estimation of enzymatic infarct size:direct comparison of the marker enzymes creatine kinase and alpha-hydroxybutyrate dehydrogenase[J]. Am Heart J,1998,135(1):1-9.
[16]Karayalcin G,Lanzkowsky P,Kari AB. Serum alpha-hydroxybutyrate dehydrogenase levels in children with sickle cell disease[J]. Am J Pediatr Hematol Oncol,1981,3(2):169-171.
[17]Lee S,Koppensteiner R,Kopp CW,et al. α-Hydroxybutyrate dehydrogenase is associated with atherothrombotic events following infrainguinal angioplasty and stenting[J]. Sci Rep,2019,9(1):18200.
[18]中国医师协会心血管外科分会大血管外科专业委员会. 主动脉夹层诊断与治疗规范中国专家共识[J]. 中华胸心血管外科杂志,2017,33(11):641-654.
[19]Fukui T. Management of acute aortic dissection and thoracic aortic rupture[J]. J Intensive Care,2018,6:15.
[20]Evangelista A,Isselbacher EM,Bossone E,et al. Insights from the international registry of acute aortic dissection:a 20-year experience of collaborative clinical research[J]. Circulation,2018,137(17):1846-1860.
[21]Gawinecka J,Sch?nrath F,von Eckardstein A. Acute aortic dissection:pathogenesis,risk factors and diagnosis[J]. Swiss Med Wkly,2017,147:w14489.
[22]Liu X,Zheng X,Su X,et al. Plasma resistin levels in patients with acute aortic dissection:a propensity score-matched observational case-control study[J]. Med Sci Monit,2018,24:6431-6437.
[23]Wu ZN,Guan XL,Xu SJ,et al. Does preoperative serum creatinine affect the early surgical outcomes of acute Stanford type A aortic dissection?[J]. J Chin Med Assoc,2020,83(3):266-271.
[24]Morello F,Ravetti A,Nazerian P,et al. Plasma lactate dehydrogenase levels predict mortality in acute aortic syndromes:a diagnostic accuracy and observational outcome study[J]. Medicine(Baltimore),2016,95(6):e2776.
[25]van der Laarse A,Hermens WT,Hollaar L,et al. Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum alpha-hydroxybutyrate dehydrogenase levels[J]. Am Heart J,1984,107(2):248-260.
[26]Orsonneau JL,Meflah K,Lustenberger P,et al. Sensitisation and visualisation of biochemical measurements using the NAD/NADH system by means of Meldola blue. I. Principle and application to the continuous flow measurement of LDH and alpha HBDH activities in serum[J]. Clin Chim Acta,1982,125 (2):177-184.
[27]Vasudevan G,Mercer DW,Varat MA. Lactic dehydrogenase isoenzyme determination in the diagnosis of acute myocardial infarction[J]. Circulation,1978,57(6):1055-1057.
[28]He H,Chai X,Zhou Y,et al. Association of lactate dehydrogenase with in-hospital mortality in patients with acute aortic dissection:a retrospective observational study[J]. Int J Hypertens,2020,2020:1347165.
[29]Elliott BA,Wilkinson JH. Serum “alpha-hydroxybutyric dehydrogenase” in myocardial infarction and in liver disease[J]. Lancet,1961,1(7179):698-709.
[30]Rosalki SB,Wilkinson JH. Serum alpha-hydroxybutyrate dehydrogenase in diagnosis[J]. JAMA,1964,189:61-63.
[31]Roth EF Jr,Bardfeld PA,Goldsmith SJ,et al. Sickle cell crisis as evaluated from measurements of hydroxybutyrate dehydrogenase and myoglobin in plasma[J]. Clin Chem,1981,27(2):314-316.
[32]Rosalki SB. Serum alpha-hydroxybutyrate dehydrogenase:a new test for myocardial infarction[J]. Br Heart J,1963,25(6):795-802.
[33]Kemp M,Donovan J,Higham H,et al. Biochemical markers of myocardial injury[J]. Br J Anaesth,2004,93(1):63-73.